All articles by Rebecca Trager – Page 46
-
-
BusinessJudges overturn J&J talc cancer claims
Two new rulings follow trend of reversing large jury-awarded damages as firm works through thousands of cases
-
NewsUproar over EPA’s plan to ban its grantees from science committees
EPA chief says members of its scientific advisory panels get ‘millions of dollars’ in grants from the agency, which poses conflicts of interest
-
BusinessHurricane damage squeezes supply chains
Industry and government working to minimise impact of shortages of olefin feedstocks and medical products
-
NewsPublic health scientists speak out against Trump nominee
Dozens of scientists ask the Senate not to endorse Trump’s pick to head the Environmental Protection Agency’s chemical safety office
-
BusinessEx-Chemours worker tried to steal trade secrets
Employee intended to sell confidential information about sodium cyanide to Chinese investors to set up competing plants
-
NewsLitany of security breaches at US government science institute revealed
National Institute of Standards and Technology’s security lapses persist, more than two years after illegal meth production was uncovered at one of its sites
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
-
NewsObama era clean power plan to be binned
US environment agency to end dalliance with country’s first limits on carbon emissions from coal-fired power plants
-
BusinessResidents sue Arkema over contamination
French chemical giant accused of releasing toxic chemicals from US plant in the wake of hurricane Harvey
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
BusinessLong road to recovery for Puerto Rico pharmaceuticals
As inhabitants begin to rebuild their lives after the devastation of hurricane Maria, the island’s drug manufacturers are recovering slowly
-
BusinessUS state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
NewsNorth Korean site identified as suspected rocket fuel facility
DPRK scientific publications reveal 1,1-dimethylhydrazine production
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessUS probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
-
NewsTrump’s latest immigration edict worries US research community
White House’s updated and expanded rules will harm the US’s scientific enterprise, science advocates and research universities warn
-
NewsUS university diversity scheme to learn from UK experience
Initiative to be launched next month will support women in science and be broadened to race and beyond
-
NewsResearchGate under pressure to restrict article sharing
International STM publisher group appears poised to take legal action against researchers’ networking site for copyright violations
-
NewsUS rules for ‘dual-use’ research found lacking
Regulations may overlook studies of concern and needlessly hamper other work